Stock Earnings

Question 1

What are Prostatype Genomics AB's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Prostatype Genomics AB has a total asset of $41, Net loss of $-41

Question 2

What are the key financial ratios for PGABF?

Accepted Answer

Prostatype Genomics AB's Current ratio is 5.12, has a Net margin is 0, sales per share of $0.

Question 3

How is Prostatype Genomics AB's revenue broken down by segment or geography?

Accepted Answer

Prostatype Genomics AB largest revenue segment is Prognostic Gene Test, at a revenue of 1,356,000 in the most earnings release.For geography, Europe is the primary market for Prostatype Genomics AB, at a revenue of 601,000.

Question 4

Is Prostatype Genomics AB profitable?

Accepted Answer

no, according to the latest financial statements, Prostatype Genomics AB has a net loss of $-41

Question 5

Does Prostatype Genomics AB have any liabilities?

Accepted Answer

yes, Prostatype Genomics AB has liability of 8

Question 6

How many outstanding shares for Prostatype Genomics AB?

Accepted Answer

Prostatype Genomics AB has a total outstanding shares of 12.37

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	1	0	0	0
Revenue Growth (YoY)	-100%	-100%	--	--	--	--
Cost of Revenue	0	-1	-2	0	-2	-3
Gross Profit	0	1	3	0	2	3
Selling, General & Admin	15	15	18	10	7	8
Research & Development	1	2	3	3	1	2
Operating Expenses	42	42	42	29	18	19
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	-45	-41	-41	-29	-15	-17
Income Tax Expense	--	--	--	--	--	--
Net Income	-45	-41	-41	-29	-15	-17
Net Income Growth	13%	0%	41%	93%	-12%	112.99%
Shares Outstanding (Diluted)	37	12.37	0.49	0.41	15.73	13.8
Shares Change (YoY)	860%	2,414%	18%	-97%	14%	42%
EPS (Diluted)	-1.22	-3.31	-84.19	-69.47	-0.99	-1.26
EPS Growth	-88%	-96%	21%	6,918%	-21%	43%
Free Cash Flow	-41	-52	-37	-27	-18	-17
Free Cash Flow Per Share	-1.1	-4.2	-75.18	-64.48	-1.14	-1.23
Gross Margin	0%	0%	300%	0%	0%	0%
Operating Margin	0%	0%	-3,900%	0%	0%	0%
Profit Margin	0%	0%	-4,100%	0%	0%	0%
Free Cash Flow Margin	0%	0%	-3,700%	0%	0%	0%
EBITDA	-39	-39	-38	-27	-15	-15
EBITDA Margin	0%	0%	-3,800%	0%	0%	0%
D&A For EBITDA	2	1	1	1	0	0
EBIT	-41	-40	-39	-28	-15	-15
EBIT Margin	0%	0%	-3,900%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Prostatype Genomics AB (PGABF) Price

PGABF Stock Price Chart

PGABF Income

Follow-Up Questions